Printer Friendly
The Free Library
14,633,950 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

PRISMA: helping to deliver information that physical therapists need.


Staying up to date as a physical therapist is a challenge because the research underpinning the science and practice of our profession is growing exponentially. (1) The growth is well illustrated by the history of randomized controlled trials (RCT). In 1929, there was only 1 RCT evaluating a physical therapy treatment; by 1972, there were 100; by 1986, 1,000; by 2005, 10,000; and today, there are more than 12,000 RCTs. As a consequence, a "mid-career" physical therapist (who graduated in 1980) now has access to 25 times more RCTs compared with when they graduated. Even with the advent of physical therapy-specific databases such as Hooked on Evidence and PEDro, it has become impossible to keep up to date by reading primary research papers: the job has just gotten too big.

An efficient way for physical therapists to keep up to date is to read recent systematic reviews. For people with little spare time, systematic reviews are a godsend because they can distill the evidence from dozens of primary studies. Although systematic reviews on the effectiveness of interventions (2) are probably the most common, there also are reviews that focus on cost-effectiveness, (3) the views of patients, (4) prognosis, (5) diagnosis, (6) clinical prediction rules, (7) psychometric properties of scales (8) or measures, (9,10) cross-cultural adaptation of self-report measures, (11) definitions of epidemiological terms, (12) and practice guidelines. (13) Most questions that arise in physical therapist practice lend themselves to evaluation within a systematic review.

Well-conducted systematic reviews identify, appraise, and summarize research in an unbiased fashion and so provide reliable information to guide clinical decision making. Unfortunately, though, not all systematic reviews are well conducted. (14) And that is where the PRISMA statement comes in. The PRISMA statement provides a checklist of items for reporting systematic reviews and meta-analyses. When this key information is reported in a review, readers are in a much better position to judge the strength and weaknesses of a review and, most importantly, to judge whether the information provided is relevant to the specific clinical question they want to answer.

About PRISMA

The Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) statement evolved from the earlier QUOROM (Quality of Reporting of Meta-analyses) statement. QUOROM was a reporting checklist for meta-analyses of RCTs; however, as noted earlier, not all systematic reviews take this form. Beyond the expanded scope, other important differences with PRISMA are items for the review protocol and registration, for the specific electronic search strategy, and for describing sources of funding. More information on PRISMA is contained in the reprinted article in this issue (15) and also at the PRISMA Web site (http://www.prisma-statement.org).

Reports of systematic reviews that attend to the PRISMA statement will provide readers with the key information they need in order to judge the value of a systematic review. It is for this reason that PTJ joins with other journals such as BMJ, Annals of Internal Medicine, PLoS Medicine, and Journal of Clinical Epidemiology in endorsing PRISMA. We will ask our authors to follow this statement when preparing manuscripts reporting a systematic review.

Those of you who have recently viewed our instructions for authors will know that PTJ has endorsed a range of reporting checklists analogous to PRISMA. PTJ asks authors to attend to the STARD statement when they report a diagnostic study, the STROBE statement when they report an observational study, and the CONSORT statement when they report an RCT. There are a number of extensions to the CONSORT statement that focus on the additional information required for reports of cluster trials and non-inferiority and equivalence trials and for trials evaluating herbal medicines or nonpharmacological interventions.

Why Read a Checklist?

Checklists like PRISMA are obviously of value to physical therapists who are preparing a manuscript; however, they do have other uses. For researchers, they provide an excellent reminder of the sorts of issues to consider when submitting a grant application to an agency such as the Foundation for Physical Therapy or National Institutes of Health. They also are useful for our reviewers and others who critically appraise research reports because the checklists specify the salient issues that need to be considered. However, reporting checklists are not designed to assess the quality of a published study. There are separate scales to assess the risk of bias (methodological quality) of a study. Examples include the QUADAS scale for diagnostic studies (16) and the PEDro scale for RCTs. (17,18)

At the end of the day, the primary purpose of PTJ is to improve patient care. PTJ has adopted the PRISMA statement to help us better communicate our content to the physical therapists who provide that care.

[DOI: 10.2522/ptj.2009.89.9.870]

References

(1) Maher CG, Moseley AM, Sherrington C, et al. A description of the trials, reviews, and practice guidelines indexed in the PEDro database. Phys Ther. 2008;88:1068-1077.

(2) Macedo LG, Maher CG, Latimer J, McAuley JH. Motor control exercise for persistent, nonspecific low back pain: a systematic review. Phys Ther. 2009;89:9-25.

(3) Peterson LE, Goodman C, Karnes EK, et al. Assessment of the quality of cost analysis literature in physical therapy. Phys Ther. 2009;89:733-755.

(4) Verbeek J, Sengers MJ, Riemens L, Haafkens J. Patient expectations of treatment for back pain: a systematic review of qualitative and quantitative studies. Spine. 2004;29:2309-2318.

(5) Pengel LHM, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: systematic review of its prognosis. BMJ. 2003;327:323-327.

(6) Henschke N, Maher CG, Refshauge KM. A systematic review identifies five "red flags" to screen for vertebral fracture in patients with low back pain. J Clin Epidemiol. 2008;61:110-118.

(7) Beneciuk JM, Bishop MD, George SZ. Clinical prediction rules for physical therapy interventions: a systematic review. Phys Ther. 2009;89:114-124.

(8) Olivo SA, Macedo LG, Gadotti IC, et al. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther. 2008;88:156-175.

(9) Costa LOP, Maher CG, Latimer J, Smeets RJEM. Reproducibility of rehabilitative ultrasound imaging for the measurement of abdominal muscle activity: a systematic review. Phys Ther. 2009;89:756-769.

(10) Blum L, Korner-Bitensky N. Usefulness of the Berg Balance Scale in stroke rehabilitation: a systematic review. Phys Ther. 2008;88:559-566.

(11) Costa LCM, Maher C, McAuley J, Costa LOP. Systematic review of cross-cultural adaptations of McGill Pain Questionnaire reveals a paucity of clinimetric testing. J Clin Epidemiol. 2009;62:934-943.

(12) Stanton TR, Latimer J, Maher CG, Hancock M. Definitions of recurrence of an episode of low back pain: a systematic review. Spine. 2009;34:E316-E322.

(13) Koes BW, van Tulder MW, Ostelo R, et al. Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine. 2001;26:2504-2513.

(14) Moseley AM, Elkins MR, Herbert RD, et al. Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy. J Clin Epidemiol. 2009 Mar 10 [Epub ahead of print].

(15) Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Phys Ther. 2009;89:873-880.

(16) Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.

(17) Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro Scale for rating quality of randomized controlled trials. Phys Ther. 2003;83:713-721.

(18) de Morton N. The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Aust J Physiother. 2009;55:129-133.

Christopher Maher, PT, PhD

Editorial Board Member, PTJ
COPYRIGHT 2009 American Physical Therapy Association, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:preferred reporting items for systematic reviews and meta-analyses
Author:Maher, Christopher
Publication:Physical Therapy
Article Type:Editorial
Geographic Code:1USA
Date:Sep 1, 2009
Words:1292
Previous Article:Exercise machine.(Product News)
Next Article:Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.(Reprint)
Topics:

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles